In a study conducted on patients with pancreatic cancer, significantly higher levels of total circulating TF (evaluated through an ELISA kit) were found at baseline in patients who further developed CAT during the study follow-up than in patients who did not. This evidence concerns the gene TF and pancreatic neoplasm.